|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
WHO007500556 |
| 003 |
DE-627 |
| 005 |
20230622115301.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210512s2023 xx |||||o 00| ||und c |
| 035 |
|
|
|a (DE-627)WHO007500556
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)PER-106-20
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)2020-003998-22
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a und
|
| 245 |
1 |
0 |
|a HERALD
|b COVID-19: A PHASE 2B/3, RANDOMIZED, OBSERVER-BLINDED, PLACEBO-CONTROLLED, MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF INVESTIGATIONAL SARS-COV-2 MRNA VACCINE CVNCOV IN ADULTS 18 YEARS OF AGE AND OLDER
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 29-12-2020, Last updated: 2023-06-22
|
| 650 |
|
4 |
|a Medical Condition: -B342 Coronavirus infection, unspecified site Coronavirus infection, unspecified site;B342;Coronavirus infection, unspecified site
|
| 650 |
|
4 |
|a Study Type: Interventional
|
| 650 |
|
4 |
|a Phase: Phase 3
|
| 650 |
|
4 |
|a Recruitment Status: Recruiting
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2023) vom: 05. Juni
|
| 773 |
1 |
8 |
|g year:2023
|g day:05
|g month:06
|
| 856 |
4 |
0 |
|u https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=106-20
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2023
|b 05
|c 06
|
Klinische Studie